Unique behavioural phenotypes of recombinant-inbred CXBK mice: Partial deficiency of sensitivity to μ- and κ-agonists

Neuroscience Research

Volumn 34, Issue 3, 1999, Pages 149-155

  Ikeda, Kazutaka ^a   Ichikawa, Tomio ^b   Kobayashi, Toru ^b   Kumanishi, Toshiro ^b   Oike, Shinsuke ^a   Yano, Ryoji ^a  

^a RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

Author keywords

Opioid receptor; Analgesia; CXBK mouse; Gene targeting mouse; Morphine; Nociceptive threshold; U 50488

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; KAPPA OPIATE RECEPTOR; MORPHINE; MU OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; GENE TARGETING; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NOCICEPTION; NONHUMAN; PAIN THRESHOLD; PHENOTYPE; PRIORITY JOURNAL;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; ANIMALS; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEAT; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MORPHINE; PAIN; PAIN THRESHOLD; PHENOTYPE; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; RECOMBINATION, GENETIC; SENSITIVITY AND SPECIFICITY; SPECIES SPECIFICITY;

EID: 0032846612     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-0102(99)00047-4     Document Type: Article

References (29)

1. Bailey D. Recombinant-inbred strains. An aid to finding identity, linkage, and function of histocompatibility and other genes. Transplantation. 11:1971;325-327.
2. Baran A., Shuster L., Eleftheriou B., Bailey D. Opiate receptors in mice: genetic differences. Life Sci. 17:1975;633-640.
3. D'Amour F., Smith D. A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72:1941;74-79.
4. Ikeda K., Araki K., Takayama C., Inoue Y., Yagi T., Aizawa S., Mishina M. Reduced spontaneous activity of mice defective in the ε4 subunit of the NMDA receptor channel. Brain Res. Mol. Brain Res. 33:1995;61-71.
5. + (GIRK) channels and functional couplings of the opioid receptors with the GIRK1 channel. Ann. New York Acad. Sci. 801:1996;95-109.
6. + (GIRK) channel. Brain Res. Mol. Brain Res. 45:1997;117-126.
7. Jiang Q., Mosberg H., Porreca F. Selective modulation of morphine antinociception, but not development of tolerance, by delta receptor agonists. Eur. J. Pharmacol. 186:1990;137-141.
8. Kest B., Beczkowska I., Franklin S., Lee C., Mogil J., Insturrisi C. Differences in delta opioid receptor antinociception, binding, and mRNA levels between BALB/c and CXBK mice. Brain Res. 805:1998;131-137.
9. Kieffer B. Molecular aspect of opioid receptors. Dickenson A., Besson J. The Pharmacology of Pain. 1997;281-303 Springer, Berlin.
10. 3H]naltriben to δ-opioid receptors in mouse brain. Eur. J. Pharmacol. 350:1998;335-344.
11. Loh H., Liu H., Cavalli A., Yang W., Chen Y., Wei L. μ Opioid receptor knockout in mice: effects on ligand-induced analgesia and morphine lethality. Brain Res. Mol. Brain Res. 54:1998;321-326.
12. Marek P., Yirmiya R., Liebeskind J. Strain differences in the magnitude of swimming-induced analgesia in mice correlate with brain opiate receptor concentration. Brain Res. 447:1988;188-190.
13. Matthes H., Maldonado R., Simonin F., Valverde O., Slowe S., Kitchen I., Befort K., Dierich A., Le Meur M., Dolle P., Tzavara E., Hanoune J., Roques B., Kieffer B. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene. Nature. 383:1996;819-823.
14. Miczek K., Thompson M., Shuster L. Opioid-like analgesia in defeated mice. Science. 215:1982;1520-1522.
15. Moskowitz A., Goodman R. Autoradiographic analysis of mu1, mu2, and delta opioid binding in the central nervous system of C57BL/6BY and CXBK (opioid receptor-deficient) mice. Brain Res. 360:1985;108-116.
16. Muraki T., Oike N., Shibata Y., Nomoto T. Analgesic effect of mu- and kappa-opioid agonists in beige and CXBK mice. J. Pharm. Pharmacol. 43:1991;210-212.
17. Pasternak G. Multiple morphine and enkephalin receptors: biochemical and pharmacological aspects. Ann. New York Acad. Sci. 467:1986;130-139.
18. Peets J., Pomeranz B. CXBK mice deficient in opiate receptors show poor electroacupuncture analgesia. Nature. 273:1978;675-676.
19. 2O) antinociception. Brain Res. 614:1993;52-56.
20. 5]enkephalin, in the mu-opioid receptor deficient CXBK mouse. Eur. J. Pharmacol. 216:1992;453-456.
21. Roques B., Noble F., Dauge V., Fournie-Zaluski M., Beaumont A. Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology. Pharmacol. Rev. 45:1993;87-146.
22. Simonin F., Valverde O., Smadja C., Slowe S., Kitchen I., Dierich A., Le Meur M., Roques B., Maldonado R., Kieffer B. Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal. EMBO J. 17:1998;886-897.
23. 5]enkephalin-induced analgesia. Eur. J. Pharmacol. 324:1997;R1-R2.
24. Sora I., Takahashi N., Funada M., Ujike H., Revay R., Donovan D., Miner L., Uhl G. Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc. Natl. Acad. Sci. USA. 94:1997;1544-1549.
25. Tian M., Broxmeyer H., Fan Y., Lai Z., Zhang S., Aronica S., Cooper S., Bigsby R., Steinmetz R., Engle S., Mestek A., Pollock J., Lehman M., Jansen H., Ying M., Stambrook P., Tischfield J., Yu L. Altered hematopoiesis, behavior, and sexual function in mu opioid receptor-deficient mice. J. Exp. Med. 185:1997;1517-1522.
26. Traynor J., Elliott J. δ-Opioid receptor subtypes and cross-talk with μ-receptors. Trends Pharmacol. Sci. 14:1993;84-86.
27. Vaught J., Mathiasen J., Raffa R. Examination of the involvement of supraspinal and spinal mu and delta opioid receptors in analgesia using the mu receptor deficient CXBK mouse. J. Pharmacol. Exp. Ther. 245:1988;13-16.
28. Wolozin B., Pasternak G. Classification of multiple morphine and enkephalin binding sites in the central nervous system. Proc. Natl. Acad. Sci. USA. 78:1981;6181-6185.
29. Woolfe G., MacDonald A. The evaluation of the analgesic action of pethidine hydrochloride (demerol). J. Pharmacol. Exp. Ther. 80:1944;300-307.